Telomir Pharmaceuticals, Inc.
TELO
$1.26
-$0.03-2.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.41M | -11.25M | -16.08M | -12.46M | -16.53M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 4.34M |
| Total Other Non-Cash Items | 6.13M | 8.33M | 13.04M | 8.37M | 7.00M |
| Change in Net Operating Assets | 594.70K | -172.60K | -126.40K | 90.80K | 126.40K |
| Cash from Operations | -3.69M | -3.09M | -3.17M | -3.99M | -5.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 155.50K | -- | -132.40K | 0.00 | 0.00 |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -101.00K |
| Issuance of Common Stock | 9.55M | 9.59M | 2.09M | 1.04M | 6.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 85.50K | 85.50K | -434.00K |
| Cash from Financing | 9.71M | 9.59M | 2.04M | 1.12M | 6.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.02M | 6.49M | -1.13M | -2.87M | 1.26M |